July 1, 2013Postgraduate Medicine

Clopidogrel, Prasugrel, or Ticagrelor? A Practical Guide to Use of Antiplatelet Agents in Patients With Acute Coronary Syndromes

View Full Paper

Ask AI

Bookmark

Population

Patients with acute coronary syndromes (ACS)

Design

Review

Authors

NNNicholas B. NorgardUniversity of Missouri–Kansas City JDJames J. DiNicolantonioSaint Luke's Health System

Discussion

Member takes

Implication

May guide P2Y12 inhibitor selection in ACS DAPT; leaves open need for updated RCTs in contemporary cohorts.

Structured PICO

Population

Patients with acute coronary syndromes (ACS)

Intervention

Clopidogrel, prasugrel, or ticagrelor added to aspirin

This review provides a practical guide for selecting the appropriate P2Y12 inhibitor for dual antiplatelet therapy in patients with acute coronary syndromes.

Cite This Study

Norgard et al. (2013) studied this question.

synapsesocial.com/papers/6a720cf431a3df824329ef59 https://doi.org/10.3810/pgm.2013.07.2682

Topics

Dual antiplatelet therapy

View Full Paper

Ask AI

Bookmark

Clopidogrel, Prasugrel, or Ticagrelor? A Practical Guide to Use of Antiplatelet Agents in Patients With Acute Coronary Syndromes

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Clopidogrel, Prasugrel, or Ticagrelor? A Practical Guide to Use of Antiplatelet Agents in Patients With Acute Coronary Syndromes

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider